Literature DB >> 17727639

Soluble oligomers from a non-disease related protein mimic Abeta-induced tau hyperphosphorylation and neurodegeneration.

Marcelo N N Vieira1, Letícia Forny-Germano, Leonardo M Saraiva, Adriano Sebollela, Ana M Blanco Martinez, Jean-Christophe Houzel, Fernanda G De Felice, Sérgio T Ferreira.   

Abstract

Protein aggregation and amyloid accumulation in different tissues are associated with cellular dysfunction and toxicity in important human pathologies, including Alzheimer's disease and various forms of systemic amyloidosis. Soluble oligomers formed at the early stages of protein aggregation have been increasingly recognized as the main toxic species in amyloid diseases. To gain insight into the mechanisms of toxicity instigated by soluble protein oligomers, we have investigated the aggregation of hen egg white lysozyme (HEWL), a normally harmless protein. HEWL initially aggregates into beta-sheet rich, roughly spherical oligomers which appear to convert with time into protofibrils and mature amyloid fibrils. HEWL oligomers are potently neurotoxic to rat cortical neurons in culture, while mature amyloid fibrils are little or non-toxic. Interestingly, when added to cortical neuronal cultures HEWL oligomers induce tau hyperphosphorylation at epitopes that are characteristically phosphorylated in neurons exposed to soluble oligomers of the amyloid-beta peptide. Furthermore, injection of HEWL oligomers in the cerebral cortices of adult rats induces extensive neurodegeneration in different brain areas. These results show that soluble oligomers from a non-disease related protein can mimic specific neuronal pathologies thought to be induced by soluble amyloid-beta peptide oligomers in Alzheimer's disease and support the notion that amyloid oligomers from different proteins may share common structural determinants that would explain their generic cytotoxicities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727639     DOI: 10.1111/j.1471-4159.2007.04809.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  29 in total

1.  Mesenchymal stem cells and cell-derived extracellular vesicles protect hippocampal neurons from oxidative stress and synapse damage induced by amyloid-β oligomers.

Authors:  Mariana A de Godoy; Leonardo M Saraiva; Luiza R P de Carvalho; Andreia Vasconcelos-Dos-Santos; Hellen J V Beiral; Alane Bernardo Ramos; Livian R de Paula Silva; Renata B Leal; Victor H S Monteiro; Carolina V Braga; Carlla A de Araujo-Silva; Leandro C Sinis; Victor Bodart-Santos; Tais Hanae Kasai-Brunswick; Carolina de Lima Alcantara; Ana Paula C A Lima; Narcisa L da Cunha-E Silva; Antonio Galina; Adalberto Vieyra; Fernanda G De Felice; Rosalia Mendez-Otero; Sergio T Ferreira
Journal:  J Biol Chem       Date:  2017-12-28       Impact factor: 5.157

2.  Plasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.

Authors:  Md Suhail Alam; Michelle Getz; Sue Yi; Jeffrey Kurkewich; Innocent Safeukui; Kasturi Haldar
Journal:  J Biol Chem       Date:  2014-01-31       Impact factor: 5.157

3.  Toll-like receptor mediated lysozyme expression in Niemann-pick disease, type C1.

Authors:  Antony Cougnoux; Julia C Yerger; Mason Fellmeth; Jenny Serra-Vinardell; Christopher A Wassif; Niamh X Cawley; Forbes D Porter
Journal:  Mol Genet Metab       Date:  2020-10-18       Impact factor: 4.797

4.  Acridine derivatives inhibit lysozyme aggregation.

Authors:  Zuzana Gazova; Andrea Bellova; Zuzana Daxnerova; Jan Imrich; Pavol Kristian; Jana Tomascikova; Jaroslava Bagelova; Diana Fedunova; Marian Antalik
Journal:  Eur Biophys J       Date:  2008-04-03       Impact factor: 1.733

5.  Expression profile of rat hippocampal neurons treated with the neuroprotective compound 2,4-dinitrophenol: up-regulation of cAMP signaling genes.

Authors:  Adriano Sebollela; Léo Freitas-Corrêa; Fábio F Oliveira; Camila T Mendes; Ana Paula Wasilewska-Sampaio; Juliana Camacho-Pereira; Antonio Galina; Helena Brentani; Fabio Passetti; Fernanda G De Felice; Emmanuel Dias-Neto; Sérgio T Ferreira
Journal:  Neurotox Res       Date:  2009-12-01       Impact factor: 3.911

6.  Amyloid Oligomers and Mature Fibrils Prepared from an Innocuous Protein Cause Diverging Cellular Death Mechanisms.

Authors:  Níal P Harte; Igor Klyubin; Eoin K McCarthy; Soyoung Min; Sarah Ann Garrahy; Yongjing Xie; Gavin P Davey; John J Boland; Michael J Rowan; K Hun Mok
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

7.  Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase.

Authors:  Estefania P C Azevedo; Anderson B Guimarães-Costa; Guilherme S Torezani; Carolina A Braga; Fernando L Palhano; Jeffery W Kelly; Elvira M Saraiva; Debora Foguel
Journal:  J Biol Chem       Date:  2012-08-23       Impact factor: 5.157

8.  Protective effects of luteolin against cognitive impairment induced by infusion of Aβ peptide in rats.

Authors:  Tian-Xia Yu; Peng Zhang; Yan Guan; Min Wang; Ming-Qing Zhen
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

9.  Structural fingerprints and their evolution during oligomeric vs. oligomer-free amyloid fibril growth.

Authors:  Joseph Foley; Shannon E Hill; Tatiana Miti; Mentor Mulaj; Marissa Ciesla; Rhonda Robeel; Christopher Persichilli; Rachel Raynes; Sandy Westerheide; Martin Muschol
Journal:  J Chem Phys       Date:  2013-09-28       Impact factor: 3.488

10.  A human scFv antibody that targets and neutralizes high molecular weight pathogenic amyloid-β oligomers.

Authors:  Adriano Sebollela; Erika N Cline; Izolda Popova; Kevin Luo; Xiaoxia Sun; Jay Ahn; Milena A Barcelos; Vanessa N Bezerra; Natalia M Lyra E Silva; Jason Patel; Nathalia R Pinheiro; Lei A Qin; Josette M Kamel; Anthea Weng; Nadia DiNunno; Adrian M Bebenek; Pauline T Velasco; Kirsten L Viola; Pascale N Lacor; Sergio T Ferreira; William L Klein
Journal:  J Neurochem       Date:  2017-08-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.